Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04741529 · ClinicalTrials.gov registry record · NA

Massed and Spaced HMP App Dosage Study

A NA study, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
351
Enrollment target

NCT04741529: Completed NA study, sponsored by University of Wisconsin, Madison.

NCT04741529 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 351 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04741529, a NA study, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
351 participants
Enrollment target

Study Summary

This study is a randomized controlled trial (RCT) of 2 weeks of the Healthy Minds Program (HMP) app Connection module in undergraduate students of a large, midwestern state university in the United States during the spring of 2021. Participants will be recruited via email and/or flyers and will first complete an online screen. Eligible participants will complete baseline measures prior to attending an introductory session via web conferencing. During this session, participants will be randomly assigned to condition. Participants in both conditions will be asked to use the HMP app for 20 minutes per either, either split over two 10-minute session (Spaced condition) or in one 20-minute session (Massed condition). Participants will complete daily survey measures during the study and post-test measures after 2 weeks of intervention. This study is primarily designed to assess feasibility and acceptability of 2 weeks of Connection training and assignment to dosage condition. Study team will investigate self-reported informal practice on the daily diary measure, measures of psychological distress (composite of depression, anxiety) and loneliness.

Interventions

  • BEHAVIORAL Healthy Minds Program app

Trial Details

FieldValue
Enrollment Target 351 participants
Start Date 2021-03-09
Est. Completion 2021-05-18
Phase NA
University of Wisconsin, Madison

1,039 total trials

What the finished NCT04741529 record still lists

NCT04741529 is an interventional study that assigns participants to a tested intervention. The registered 351 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).

The record links to 0 conditions, and to 1 intervention - of which Healthy Minds Program app is the first listed.

NCT04741529 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04741529 about?

NCT04741529 is a clinical study titled "Massed and Spaced HMP App Dosage Study". This study is a randomized controlled trial (RCT) of 2 weeks of the Healthy Minds Program (HMP) app Connection module in undergraduate students of a large, midwestern state university in the United States during the spring of 2021. Participants will be recruited via email and/or flyers and will fir...

What is the current status of trial NCT04741529?

This trial is currently completed. It is a NA study. The enrollment target is 351 participants. The study started on 2021-03-09. Estimated completion is 2021-05-18.

What interventions are being tested in trial NCT04741529?

The interventions under investigation include: Healthy Minds Program app (BEHAVIORAL).

Who is sponsoring clinical trial NCT04741529?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04741529's enrollment target sits among peer trials

351 292nd of 2000 higher than 1,709 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06241456 · 351 participants · Phase 1

    FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors

  • NCT06576726 · 351 participants

    Sensorimotor and Psychosocial Trajectories in Adolescents With Tic Disorder

  • NCT07043400 · 351 participants · Phase 3

    A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

  • NCT07261423 · 351 participants · NA

    Pollution Intervention to Impact Kids Asthma Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04741529, the US trial registry maintained by the National Library of Medicine. NCT04741529 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.